Delivery Order SPE2DB24D2215-SPE2DB25FGTHH
- Not listed
- The Defense Logistics Agency awarded a $1,089.72 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cipro 5% Suspension in 100ml quantities. This firm fixed-price contract, with an ultimate completion date of September 2, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procedures with no set-aside designation, and the product will be...
- The Defense Logistics Agency awarded a $3,103.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Cipro 5% Suspension in 100ml quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cipro 10% Suspension in 100ML quantities, with a ceiling value of $2,985.58 and an ultimate completion date of April 22, 2025. This competitively awarded, firm fixed price delivery order represents a non-set-aside procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at...
- The Defense Logistics Agency awarded a $2,967.88 delivery order to AmerisourceBergen Drug Corp for 100ml of Cipro 5% Suspension on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed price contract represents a non-set-aside award issued under competitive procurement procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,649.57 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Cipro 5% Suspension in 100ml units. This competitive award employs firm fixed-price pricing and carries an ultimate completion date of August 28, 2025, with no set-aside designation. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,210.72 to AmerisourceBergen Drug Corp for Cipro 10% Suspension 100ML, a broad-spectrum antibiotic pharmaceutical product. The contract utilized firm fixed price pricing with no set-aside designation, indicating competitive award through an open procurement process. The delivery order is scheduled for completion by August 1, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML with a ceiling value of $1,079.02. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, valued at $999.99 billion through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cipro 5% Suspension in 100ml quantities, with a ceiling value of $2,103.45. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025. The award was made on a competitive, non-set-aside basis and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100ml of Cipro 5% Suspension with a ceiling value of $1,227.35. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The delivery order was executed on August 27, 2025, with an ultimate completion date of August 28, 2025, and performance will take place at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,461.98 to AmerisourceBergen Drug Corp for Cipro 5% Suspension in 100ml quantities, with a firm fixed price contract type. The award was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitive award carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting...
- SPE2DB24D2215Indefinite Delivery Contract
- SPE2DB24D2215-SPE2DB25FGTHHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,143.32 to AmerisourceBergen Drug Corp for Cipro 5% Suspension in 100ml quantities on September 3, 2025, with completion targeted for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through December 2026 that supports global military healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies an extensive portfolio of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for the antibiotic Cipro suspension is consistent with the company's established role in providing both specialty and generic medications across multiple therapeutic domains to military and veteran healthcare systems through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/3/25 |